SEIA
INO icon

Signature Estate & Investment Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Signature Estate & Investment Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Hold
11,028
– – ﹤0.01% 667
2026
Q1 		$19.2K Hold
11,028
– – ﹤0.01% 645
2025
Q4 		$19.2K Hold
11,028
– – ﹤0.01% 604
2025
Q3 		$25.8K Hold
11,028
– – ﹤0.01% 597
2025
Q2 		$22.4K Hold
11,028
– – ﹤0.01% 575
2025
Q1 		$18K Hold
11,028
– – ﹤0.01% 547
2024
Q4 		$20.2K Buy
11,028
+152
+1% +$673 ﹤0.01% 537
2024
Q3 		$62.9K Hold
10,876
– – ﹤0.01% 519
2024
Q2 		$87.9K Buy
+10,876
New +$114K ﹤0.01% 500

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Signature Estate & Investment Advisors's INO Position: Q2 2026 in Review

Signature Estate & Investment Advisors held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 11,028 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Signature Estate & Investment Advisors first reported a position in INO in Q2 2024 and has held it in 9 quarters since. The position peaked at $87.9K in Q2 2024. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Signature Estate & Investment Advisors held 11,028 shares of Inovio Pharmaceuticals worth $12.1K as of Q2 2026.
  • Signature Estate & Investment Advisors left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #667 holding.
  • Signature Estate & Investment Advisors first reported a position in Inovio Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Signature Estate & Investment Advisors's Inovio Pharmaceuticals position peaked at $87.9K in Q2 2024.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.